Enzo Biochem, Inc. ENZ

NYS: ENZ | ISIN: US2941001024 29/04/2025

0,490 USD (+1,87%)

(+1,87%) 29/04/2025

Grafiek Enzo Biochem, Inc.

Grafiek Enzo Biochem, Inc.

1 dag1d 1,87%
1 week1w -0,02%
1 maand1m 44,09%
3 maanden3m -15,91%
6 maanden6m -56,65%
1 jaar1j -52,89%
5 jaar5j -82,99%

Enzo Biochem, Inc. in het nieuws

Toon enkel gratis nieuws

17 maart 2021 · Enzo Biochem To Present At The Keybanc Capital Markets' Life Sciences & Medtech Investor Forum · Persbericht

15 maart 2021 · Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates · Persbericht

4 maart 2021 · Enzo Biochem to Participate in the H.C. Wainwright Global Life Sciences Conference · Persbericht

3 februari 2021 · Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin · Persbericht

20 januari 2021 · Enzo Biochem’s Board Of Directors Forms New Corporate Development And Planning & Succession Committees · Persbericht

5 januari 2021 · Roumell Announces Preliminary Annual Meeting Results for Enzo Biochem, Inc. · Persbericht

4 januari 2021 · ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR TESTING POOLED SAMPLES ON THREE PLATFORMS INCLUDING COMPANY’S GENFLEX™ PROPRIETARY SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2 · Persbericht

Profiel Enzo Biochem, Inc.

Gezondheidstechnologie

Professionele, wetenschappelijke en technische diensten

Testlaboratoria

Website: www.enzo.com

Hoofdzetel: Farmingdale, New York Verenigde Staten

CEO: Elazar Rabbani

Werknemers: 85

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe